Xian-Jun Yu: Clinical Trials

7 trials sponsored by Xian-Jun Yu, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown, 2 completed, 1 recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Not applicable1Unknown 1
Phase 11Recruiting 1

Follow Xian-Jun Yu: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of RGL-270 Single Drug and Combined With Adebelimab in Patients in Patients at High Risk of Recurrence After Radical Treatment of Malignant Solid Tumors
RGL-270 Injection, Adebelimab Injection - Tumor, Solid
Phase 1RecruitingXian-Jun Yu1982025-09-072026-01-16
Neuroendocrine Neoplasm Based on Multi-omics Integrated Analysis
Biopsy/surgical tissue and peripheral blood - Neuroendocrine Neoplasm
UnknownXian-Jun Yu2002021-07-012021-06-18
he Safety Research of Timing of the Removal of Abdominal Drains After Pancreatic Surgery
drainage tube was removed on 5th days after surgery., drainage tube was removed on 7th days after surgery. - Safety Issues
UnknownXian-Jun Yu1142021-06-012021-05-19
Comparing Early Enteral Nutrition Versus Parenteral Nutrition After Pancreaticoduodenectomy
Total parenteral nutrition, Enteral nutrition - Enteral Nutrition
Not applicableUnknownXian-Jun Yu2102021-02-012021-01-12
The Influence of Antibiotics on the Incidence of Biliary Tract Infections After PTCD for Malignant Obstructive Jaundice
antibiotic - The Influence of Antibiotics on the Incidence of Biliary Tract Infections After PTCD for Malignant Obstructive Jaundice
UnknownXian-Jun Yu1202020-10-202020-11-09
Nab-paclitaxel Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection
nab-paclitaxel, gemcitabine - Stage IA Pancreatic Adenocarcinoma, Stage IB Pancreatic Adenocarcinoma
Phase 2CompletedXian-Jun Yu802014-01-012019-02-05
Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection
Gemcitabine, Metformin, placebo - Stage IA Pancreatic Adenocarcinoma, Stage IB Pancreatic Adenocarcinoma
Phase 2CompletedXian-Jun Yu3002013-12-012019-02-05

Conditions studied

Pancreatic Neoplasms (2)  ·  Neoplasms (1)  ·  Neuroendocrine Tumors (1)

Interventions

Gemcitabine (2)  ·  130-nm albumin-bound paclitaxel (1)  ·  Albumin-Bound Paclitaxel (1)  ·  Anti-Bacterial Agents (1)  ·  Biopsy (1)  ·  Enteral Nutrition (1)  ·  Metformin (1)  ·  Parenteral Nutrition, Total (1)

Countries

China (7)

Top investigators

Xianjun F Yu (1)  ·  Xianjun Yu, M.D., Ph.D. (1)  ·  Xianjun Yu, MD, PhD (1)